Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV - Post by User

Bullboard Posts
Comment by Simon1707on Jun 28, 2011 12:06pm
184 Views
Post# 18774292

RE: RE: Only anonymous...

RE: RE: Only anonymous...Ok, here is what I think.

1- seems to me there was insider buying in the last 10 cents PP

May 27/11 Burton, Jolyon Direct Ownership Prospectus exempt buy Warrants 0.100 1,225,000 66% 3,076,917
May 27/11 Burton, Jolyon Direct Ownership Opening report Warrants 0.000 0 0% 1,851,917
May 27/11 Burton, Jolyon Direct Ownership Prospectus exempt buy Common Shares 0.100 2,450,000 > 100% 3,717,117
May 27/11 Burton, Jolyon Direct Ownership Opening report Common Shares 0.000 0 0% 1,267,117
Apr 21/11 Panchal, Chandra Direct Ownership Compensation for services Common Shares 0.100 204,000 > 100% 366,500
Apr 19/11 Khalifa, Amin Direct Ownership Prospectus exempt buy Common Shares 0.100 322,000 21% 1,822,000
Apr 19/11 Brault, Jacques Direct Ownership Prospectus exempt buy Common Shares 0.100 194,000 > 100% 344,000


2- Mr Burton bought heavily has an investor... and now is a privy investor with more then 10% of the float... he must think that good times are ahead...

3- April 13th, they retain the Richmond Club for investor's relation

4- May 10th, they announce that Charlotte Foster is hired as director of marketing and sale...

look at her CV 

She was recently Director, Business Operations with Pfizer Animal Health Canada. Previous to Pfizer,
Foster was General Manager for Schering-Plough Animal Health Canada for 15 years and was the
Canadian Integration Lead as the result of Schering-Plough’s worldwide acquisition of Organon
Bioscience and Intervet Corporation. Foster was also marketing manager with Merck Agvet. Foster
is a past chair of the Canadian Animal Health Institute.

This is a pretty impressive catch for the company... she isn't joining a small jr company for nothing... there must be a reason... and they won't spend money on her if they don't think things should move soon...

So, for these reasons, I think interesting things are ahead of us... or else, why doing all this stuff for nothing?

What do you think?
Bullboard Posts